These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3510855)

  • 21. Effects of pioglitazone on hepatic and peripheral insulin resistance in Wistar fatty rats.
    Sugiyama Y; Shimura Y; Ikeda H
    Arzneimittelforschung; 1990 Apr; 40(4):436-40. PubMed ID: 2192715
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of glucose homeostasis in humans with denervated livers.
    Perseghin G; Regalia E; Battezzati A; Vergani S; Pulvirenti A; Terruzzi I; Baratti D; Bozzetti F; Mazzaferro V; Luzi L
    J Clin Invest; 1997 Aug; 100(4):931-41. PubMed ID: 9259593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liver-selective glucocorticoid receptor antagonism decreases glucose production and increases glucose disposal, ameliorating insulin resistance.
    Zinker B; Mika A; Nguyen P; Wilcox D; Ohman L; von Geldern TW; Opgenorth T; Jacobson P
    Metabolism; 2007 Mar; 56(3):380-7. PubMed ID: 17292727
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulinotropic agent ID-1101 (4-hydroxyisoleucine) activates insulin signaling in rat.
    Broca C; Breil V; Cruciani-Guglielmacci C; Manteghetti M; Rouault C; Derouet M; Rizkalla S; Pau B; Petit P; Ribes G; Ktorza A; Gross R; Reach G; Taouis M
    Am J Physiol Endocrinol Metab; 2004 Sep; 287(3):E463-71. PubMed ID: 15082420
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Central glucocorticoid regulation of parasympathetic drive to pancreatic B-cells in the obese fa/fa rat.
    Stubbs M; York DA
    Int J Obes; 1991 Aug; 15(8):547-53. PubMed ID: 1938098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects.
    DeFronzo RA; Barzilai N; Simonson DC
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1294-301. PubMed ID: 1955512
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The leptin-like effects of 3-d peripheral administration of a melanocortin agonist are more marked in genetically obese Zucker (fa/fa) than in lean rats.
    Cettour-Rose P; Rohner-Jeanrenaud F
    Endocrinology; 2002 Jun; 143(6):2277-83. PubMed ID: 12021192
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recombinant human insulin-like growth factor I treatment for 1 week improves metabolic control in type 2 diabetes by ameliorating hepatic and muscle insulin resistance.
    Cusi K; DeFronzo R
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3077-84. PubMed ID: 10999789
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of adrenalectomy on in vivo glucose metabolism in insulin resistant Zucker obese rats.
    Freedman MR; Stern JS; Reaven GM; Mondon CE
    Horm Metab Res; 1986 May; 18(5):296-8. PubMed ID: 3522389
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glucose effectiveness, peripheral and hepatic insulin sensitivity, in obese and lean prepubertal children.
    Hoffman RP; Armstrong PT
    Int J Obes Relat Metab Disord; 1996 Jun; 20(6):521-5. PubMed ID: 8782727
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor detect of insulin action.
    Rizza RA; Mandarino LJ; Gerich JE
    J Clin Endocrinol Metab; 1982 Jan; 54(1):131-8. PubMed ID: 7033265
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simultaneous insulinlike growth factor I and insulin resistance in obese Zucker rats.
    Jacob RJ; Sherwin RS; Greenawalt K; Shulman GI
    Diabetes; 1992 Jun; 41(6):691-7. PubMed ID: 1587396
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulin resistance in the heart: studies on isolated cardiocytes of genetically obese Zucker rats.
    Eckel J; Wirdeier A; Herberg L; Reinauer H
    Endocrinology; 1985 Apr; 116(4):1529-34. PubMed ID: 3882413
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Obesity and insulin resistance in humans: a dose-response study.
    Bonadonna RC; Groop L; Kraemer N; Ferrannini E; Del Prato S; DeFronzo RA
    Metabolism; 1990 May; 39(5):452-9. PubMed ID: 2186255
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Free fatty acids increase basal hepatic glucose production and induce hepatic insulin resistance at different sites.
    Lam TK; van de Werve G; Giacca A
    Am J Physiol Endocrinol Metab; 2003 Feb; 284(2):E281-90. PubMed ID: 12531742
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An in vivo and in vitro study of the mechanism of prednisone-induced insulin resistance in healthy subjects.
    Pagano G; Cavallo-Perin P; Cassader M; Bruno A; Ozzello A; Masciola P; Dall'omo AM; Imbimbo B
    J Clin Invest; 1983 Nov; 72(5):1814-20. PubMed ID: 6355186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The set point for maternal glucose homeostasis is lowered during late pregnancy in the rat: the role of the islet beta-cell and liver.
    Nolan CJ; Proietto J
    Diabetologia; 1996 Jul; 39(7):785-92. PubMed ID: 8817102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased insulin sensitivity and responsiveness during lactation in rats.
    Burnol AF; Leturque A; Ferré P; Kande J; Girard J
    Am J Physiol; 1986 Nov; 251(5 Pt 1):E537-41. PubMed ID: 3535531
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin sensitivity and response in eviscerated obese Zucker rats.
    Smith OL; Czech MP
    Metabolism; 1983 Jun; 32(6):597-602. PubMed ID: 6341774
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glucose metabolism in obesity: influence of body fat distribution.
    Peiris AN; Struve MF; Mueller RA; Lee MB; Kissebah AH
    J Clin Endocrinol Metab; 1988 Oct; 67(4):760-7. PubMed ID: 3047162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.